Kanpo Next Partners

Kanpo Next Partners operates as a wholly-owned subsidiary of Japan Post Insurance, the life insurance arm of the Japan Post Holdings group. The firm invests from the insurance company's general account balance sheet, giving it permanent capital with no third-party fundraising requirements. Investment decisions ultimately report through Japan Post Insurance's investment management division and are subject to Japanese Financial Services Agency regulation.

The firm's primary deployment concentrates on Japan-based early-stage technology companies, but its mandate extends to selective investments in Southeast Asia and Israel. International deals are underwritten when a portfolio company can benefit from a strategic commercial relationship with Japan Post Group's insurance, banking, or logistics operations. The firm does not pursue geographic diversification for its own sake.

The firm typically writes equity checks ranging from approximately ¥100 million to ¥500 million, targeting late-seed through Series B rounds. This capital comes from Japan Post Insurance's general account, which held roughly ¥74 trillion in total assets as of the most recent public disclosures, allowing the firm to follow on into subsequent rounds when a commercial partnership thesis continues to develop.

Sourcing flows through three primary channels: direct outreach from startups seeking a Japan Post Group commercial relationship, co-investor referrals from domestic Japanese venture firms, and introductions from global funds maintaining active Japan practices. The firm's position inside Japan Post Insurance gives it visibility into enterprise procurement needs that inform thematic screens before formal deal evaluation begins.

No. The firm is a corporate venture capital vehicle operating from a permanent balance sheet rather than a closed-end fund structure with limited partners. It does not charge management fees or carry to external investors. Its return expectations fold in strategic enterprise value created for the parent alongside equity appreciation, placing it closer on the spectrum to a strategic corporate development unit than an independent GP pursuing purely financial returns.